We will be there
New hem-onc approaches at EHA2019
CAR T-Cells will surely be the hot topic both on a clinical and commercial standpoints. More to follow!
Latest clinical results at ASCO2019
Immune checkpoints, targeted therapies and chemotherapies combinations to be showcased.
Next generation IOs at AACR2019
More advanced results expected for LAG-3 inhibitors, STING agonists, TIM-3 inhibitors along with other promising early stage developments.
©2019 ONKOS consulting